|

The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry

RECRUITINGSponsored by Deutsches Herzzentrum Muenchen
Actively Recruiting
SponsorDeutsches Herzzentrum Muenchen
Started2020-09-15
Est. completion2030-12-31
Eligibility
Age18 Years – 110 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04577248

Summary

Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.

Eligibility

Age: 18 Years – 110 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age above 18 years and consentable
* Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
* Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
* Written informed consent

Exclusion Criteria:

* Patient's inability to fully cooperate with the protocol

Conditions4

Heart DiseaseMitral Valve RegurgitationMitral Valve StenosisTricuspid Valve Regurgitation

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.